CASU, Gavino
 Distribuzione geografica
Continente #
AS - Asia 3.279
NA - Nord America 3.252
SA - Sud America 2.508
EU - Europa 1.125
AF - Africa 121
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 5
Totale 10.296
Nazione #
US - Stati Uniti d'America 3.098
BR - Brasile 2.241
SG - Singapore 1.843
CN - Cina 493
IT - Italia 379
HK - Hong Kong 322
DE - Germania 197
VN - Vietnam 161
AR - Argentina 93
UA - Ucraina 83
FI - Finlandia 70
RU - Federazione Russa 70
TR - Turchia 66
CA - Canada 65
GB - Regno Unito 60
MX - Messico 56
EC - Ecuador 54
FR - Francia 51
IN - India 48
BD - Bangladesh 47
IQ - Iraq 46
UZ - Uzbekistan 41
ZA - Sudafrica 38
SE - Svezia 36
AT - Austria 35
VE - Venezuela 34
NL - Olanda 31
JP - Giappone 29
CO - Colombia 25
KR - Corea 24
PL - Polonia 21
PK - Pakistan 20
CZ - Repubblica Ceca 19
MA - Marocco 19
PY - Paraguay 18
ID - Indonesia 17
KE - Kenya 17
PE - Perù 16
ES - Italia 15
KZ - Kazakistan 14
TN - Tunisia 14
AZ - Azerbaigian 13
NP - Nepal 13
DZ - Algeria 12
JO - Giordania 12
LT - Lituania 12
CL - Cile 11
UY - Uruguay 10
AE - Emirati Arabi Uniti 9
BE - Belgio 8
SA - Arabia Saudita 8
DO - Repubblica Dominicana 7
EG - Egitto 7
KG - Kirghizistan 7
LB - Libano 7
PA - Panama 7
XK - ???statistics.table.value.countryCode.XK??? 6
AL - Albania 5
IL - Israele 5
AU - Australia 4
BO - Bolivia 4
HN - Honduras 4
JM - Giamaica 4
PH - Filippine 4
RO - Romania 4
RS - Serbia 4
SN - Senegal 4
BG - Bulgaria 3
CG - Congo 3
CR - Costa Rica 3
GE - Georgia 3
GR - Grecia 3
HU - Ungheria 3
LV - Lettonia 3
NI - Nicaragua 3
OM - Oman 3
AO - Angola 2
BH - Bahrain 2
BN - Brunei Darussalam 2
CH - Svizzera 2
ET - Etiopia 2
KW - Kuwait 2
LU - Lussemburgo 2
MD - Moldavia 2
MN - Mongolia 2
MY - Malesia 2
NG - Nigeria 2
PS - Palestinian Territory 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
BB - Barbados 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CY - Cipro 1
DK - Danimarca 1
GT - Guatemala 1
GY - Guiana 1
Totale 10.285
Città #
Dallas 1.966
Singapore 986
Hong Kong 320
Beijing 212
São Paulo 168
Ashburn 152
Shanghai 112
Los Angeles 71
Munich 71
Chandler 67
Belo Horizonte 66
Rio de Janeiro 63
Santa Clara 60
Ho Chi Minh City 57
New York 51
Brasília 42
Curitiba 42
Helsinki 40
Hanoi 38
Tashkent 35
Nuremberg 34
Jacksonville 33
Porto Alegre 33
Boardman 27
Tokyo 27
Campinas 26
Romola 26
Brooklyn 24
Seoul 24
Frankfurt am Main 23
Johannesburg 23
Sassari 23
Baghdad 22
Montreal 22
Princeton 22
Tianjin 22
Rome 21
Ann Arbor 20
Düsseldorf 20
Guayaquil 20
Milan 20
Ribeirão Preto 20
Warsaw 20
Salvador 19
Wilmington 19
Guarulhos 18
Boston 17
Quito 17
Vienna 17
Falkenstein 16
Istanbul 16
Nairobi 16
Santo André 16
Uberlândia 16
Denver 15
Stockholm 15
Toronto 15
Belford Roxo 14
Buenos Aires 14
Orem 14
Sorocaba 14
Baku 13
Betim 13
Cagliari 13
Chennai 13
Dearborn 13
Juiz de Fora 13
Lima 13
London 13
Nanjing 13
Amsterdam 12
Brno 12
Gravataí 12
Mauá 12
São José dos Campos 12
Turku 12
Amman 11
Ankara 11
Aracaju 11
Canoas 11
Caracas 11
Dhaka 11
Goiânia 11
João Pessoa 11
Asunción 10
Atlanta 10
Campo Grande 10
Fortaleza 10
Franca 10
Houston 10
Joinville 10
Lappeenranta 10
Manaus 10
Mexico City 10
Poplar 10
San Francisco 10
Campos dos Goytacazes 9
Columbus 9
Cuiabá 9
Ipatinga 9
Totale 5.892
Nome #
Left atrial appendage occlusion: behind the bleeding risk 210
Left Atrial Appendage Closure vs. Oral Anticoagulation: still a matter of debate 154
Case Report: Dangerous liaisons between splenectomy and eltrombopag-induced chronic thromboembolic pulmonary hypertension in patients with immune thrombocytopenia: report of two cases and review of the literature 152
Brain anticipatory cardiovascular responses to exercise 144
Permanent pacemaker dependency after transcatheter aortic valve implantation: Prevalence, patients’ characteristics, and main determinants 136
Albumina plasmatica come indice prognostico nei pazienti con ictus cerebrale ischemico. 132
Glomerular filtration rate: A prognostic marker in atrial fibrillation—A subanalysis of the AntiThrombotic Agents Atrial Fibrillation 116
Follicular spicules and multiple ulcers: cutaneous manifestations of multiple myeloma 116
Aging of the Arterial System 113
Antiarrhythmic strategies in patients with atrial fibrillation managed by cardiologists and internists 111
Association of sex with in-hospital management and outcomes of patients with heart failure: Data from the REAL-HF registry 108
Diagnosis of Brugada syndrome affects quality of life and psychological status 103
Prevalence and clinical significance of electrocardiographic signs of atrial myopathy in rheumatoid arthritis: results from the EDRA study 102
Spicule follicolari del volto: una manifestazione cutanea peculiare del mieloma multiplo con crioglobulinemia 101
Antithrombotic strategies in the catheterization laboratory for patients with acute coronary syndromes undergoing percutaneous coronary interventions: Insights from the EmploYEd antithrombotic therapies in patients with acute coronary Syndromes HOspitalized in Italian cardiac care units Registry 100
Integrating Pharmacological Features to Personalized Models With Statin Therapy 99
ANMCO/AIAC/SICI-GISE/SIC/SICCH Consensus document: Percutaneous left atrial appendage occlusion in patients with nonvalvular atrial fibrillation: Indications, patient selection, competences, organization, and operator training 96
Long-Term Outcomes of Transcatheter vs Surgical Aortic Valve Replacement: Meta-Analysis of Randomized Trials 96
Association of chromosome 9p21 with subsequent coronary heart disease events: A GENIUS-CHD study of individual participant data 95
Acute Kidney Injury After Radial or Femoral Access for Invasive Acute Coronary Syndrome Management: AKI-MATRIX 94
Serum albumin and mortality risk in old patients with acute ischemic stroke. 94
Anticoagulant selection in relation to the SAMe-TT2R2 score in patients with atrial fibrillation: The GLORIA-AF registry 91
Maintenance therapy with a P2Y12 receptor inhibitor after cangrelor in patients with acute coronary syndrome. The ELECTRA-SIRIO 2 investigators’ viewpoint 90
Cerebral amyloid angiopathy and atrial fibrillation: a dangerous combination 88
Prevalence and risk factors for pulmonary arterial hypertension in a large group of β-thalassemia patients using right heart catheterization: A webthal study 85
ANMCO/AIAC/SICI-GISE/SIC/SICCH Consensus Document: Percutaneous occlusion of the left atrial appendage in non-valvular atrial fibrillation patients: Indications, patient selection, staff skills, organisation, and training 84
Left Atrial Appendage Occlusion in Patients With Non-Valvular Atrial Fibrillation and Cerebral Amyloid Angiopathy: Insights From the LOGIC (Left atrial appendage Occlusion in patients with Gastrointestinal or IntraCranial bleeding) International Multicenter Registry 84
Clinical outcomes of left atrial appendage occlusion in patients with previous intracranial or gastrointestinal bleeding: Insights from the LOGIC (Left atrial appendage Occlusion in patients with Gastrointestinal or IntraCranial bleeding) International Multicenter Registry 84
Safety and Efficacy of Single Versus Dual Antiplatelet Therapy After Left Atrial Appendage Occlusion 82
Ictus cerebale ischemico e infiammazione: nuovi indici di prognosi. 82
Long‐term gender disparities in new‐onset heart failure after acute coronary syndrome 81
Correction to: Outcomes on safety and efficacy of left atrial appendage occlusion in end stage renal disease patients undergoing dialysis (Journal of Nephrology, (2021), 34, 1, (63-73), 10.1007/s40620-020-00774-5) 81
"A heterozygous mutation of the elastin gene ( ELN: p.val154met) fully co-segregates with classic marfan phenotype in a sardinian family: a possible novel disease-gene?" 80
Impact of in-Hospital Left Ventricular Ejection Fraction Recovery on Long-Term Outcomes in Patients Who Underwent Impella Support for HR PCI or Cardiogenic Shock: A Sub-Analysis from the IMP-IT Registry 79
Abstract 110: Quality of life in Beta Thalassemia 79
Effect of rhTSH on Lipids 78
Clinical application of virtual reality in patients with cardiovascular disease: state of the art 77
Right Ventricular Strain Curve Morphology and Outcome in Idiopathic Pulmonary Arterial Hypertension 77
Integration of “Omics” Strategies for Biomarkers Discovery and for the Elucidation of Molecular Mechanisms Underlying Brugada Syndrome 76
Safety, efficacy, and reproducibility of cavotricuspid isthmus ablation guided by the ablation index: Acute results of the FLAI study 75
Outcomes on safety and efficacy of left atrial appendage occlusion in end stage renal disease patients undergoing dialysis 75
How do cardiologists select patients for dual antiplatelet therapy continuation beyond 1 year after a myocardial infarction? Insights from the EYESHOT Post-MI Study 75
An ensemble machine learning approach for predicting heart failure risk in acute coronary syndrome patients: heartguardai 75
Efficacy and Safety of P2Y12 monotherapy vs standard DAPT in patients undergoing percutaneous coronary intervention: meta-analysis of randomized trials 74
A double left anterior descending coronary artery emerging from the right Valsalva sinus: A case report and a brief literature review 73
Antegrade fenestration and re-entry for bailout treatment of iatrogenic coronary dissection 73
Mortality in β-thalassemia patients with confirmed pulmonary arterial hypertension on right heart catheterization 72
Atrial Fibrillation in Patients Undergoing Transcatheter Mitral Valve Repair: More Than Meets the Eye? 72
Allergic Myocardial Infarction: An Unusual Cause of Stent Thrombosis 71
Device-related complications after Impella mechanical circulatory support implantation: An IMP-IT observational multicentre registry substudy 71
Impact of SMART Pass filter in patients with ajmaline-induced Brugada syndrome and subcutaneous implantable cardioverter-defibrillator eligibility failure: results from a prospective multicentre study 71
Virtual reality and cardiac rehabilitation: a new middle-range theory to outline its mechanism of effectiveness 70
Highly specialized stroke care improves the 30-day survival 70
Anomalous origin of right coronary artery from left sinus of valsalva 69
Improving adherence to rehabilitation for heart failure patients through immersive virtual reality (VIRTUAL-HF): A protocol for a randomized controlled trial 69
Right ventricular phenotyping in incident patients with idiopathic pulmonary arterial hypertension 69
Early Diffusion of SARS-CoV-2 Infection in the Inner Area of the Italian Sardinia Island 68
Vascular assisted-tracking for challenging transradial percutaneous intervention 68
Intra-Cardiac versus Transesophageal Echocardiographic Guidance for Left Atrial Appendage Occlusion with a Watchman FLX Device 67
The experience of immersive virtual reality in patients with heart failure during cardiac rehabilitation: a qualitative study 67
Real-world clinical outcomes with a next-generation left atrial appendage closure device: the FLXibility Post-Approval Study 66
The Therapy and Management of Heart Failure with Preserved Ejection Fraction: New Insights on Treatment 66
Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial 66
Microplastics and nanoplastics in cardiovascular disease—a narrative review with worrying links 66
Correspondence 66
Left atrial appendage occlusion in atrial fibrillation patients with previous intracranial bleeding: A national multicenter study 66
Spontaneous Retrograde Embolization From an Infarct-Related Artery to a Bystander Nonculprit Artery: An Unclear Pathophysiological Mechanism? 65
Diuretic therapy in heart failure - Current approaches 64
Letter to the editor 64
Implant success and safety of left atrial appendage occlusion in end stage renal disease patients: Peri-procedural outcomes from an Italian dialysis population 63
Appropriateness criteria for the management of lipid-lowering therapy with alirocumab in high cardiovascular risk patients. The opinion of a multidisciplinary group of Italian experts 63
Theoretical basis for a new approach of studying Emery-Dreifuss muscular dystrophy by means of thermography 62
Long-term safety and efficacy of left atrial appendage occlusion in dialysis patients with atrial fibrillation: a multi-center, prospective, open label, observational study 62
Gaps in evidence in the treatment of prevalent patients with pulmonary arterial hypertension at intermediate risk: An expert consensus 62
Subsequent Event Risk in Individuals With Established Coronary Heart Disease 62
Chronic thromboembolic pulmonary hypertension risk score evaluation and validation (CTEPH SOLUTION): proposal of a study protocol aimed to realize a validated risk score for early diagnosis 60
Hemodynamics and risk assessment 2 years after the initiation of upfront ambrisentan‒tadalafil in pulmonary arterial hypertension 60
EFNB2 haploinsufficiency causes a syndromic neurodevelopmental disorder 60
Relevance of Echocardiography-derived Phenotyping in Patients with Pulmonary Arterial Hypertension Treated with Initial Oral Combination Therapy: An Italian Pulmonary Hypertension Network (iPHNET) Study 60
Prevalence of the RR genotypes of the locus ACTN3-R577X in Italian Muay Thai elite fighters 59
The value of wearable cardioverter defibrillator in adult patients with recent myocardial infarction: Economic and clinical implications from a health technology assessment perspective 59
Periprocedural outcome in patients undergoing left atrial appendage occlusion with the Watchman FLX device: The ITALIAN-FLX registry 59
Regional disparities in the management and outcomes of ST-elevation myocardial infarction: an Italian analysis focusing on time-dependent reperfusion networks and in-hospital logistics 58
When Atrial Fibrillation Meets Cerebral Amyloid Angiopathy: Current Evidence and Strategies 58
Current presentation and management of 7148 patients with atrial fibrillation in cardiology and internal medicine hospital centers: The ATA AF study 58
The paradox of pulmonary arterial hypertension in Italy in the COVID-19 era: is risk of disease progression around the corner? 58
Changing place, changing future: Repositioning a subcutaneous implantable cardioverter-defibrillator can resolve inappropriate shocks secondary to myopotential oversensing 58
Impact of Selection Bias on Estimation of Subsequent Event Risk 58
Computed Tomography and Frailty Assessment in Transcatheter Aortic Valve Implantation Candidates: Can We Kill Two Birds With One Stone? 58
Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era 57
Contemporary antithrombotic strategies in patients with acute coronary syndromes managed without revascularization: Insights fromthe EYESHOT study 57
Safety and efficacy of a light antithrombotic regimen after left atrial appendage occlusion: Insights from the LOGIC (left atrial appendage occlusion in patients with gastrointestinal or IntraCranial bleeding) international multicenter registry 57
Inside the “Razor Effect”: Lessons From Optical Coherence Tomography—What Does Angiography Hide? 57
Brugada phenocopy in a patient with unstable angina and three-vessel coronary artery disease 56
Novel Perspectives on Genetic Evaluation in Early-Onset Atrial Fibrillation: Clinical Implications and Future Directions 56
The Italian registry of renal denervation 56
Predictors of inappropriate shock in Brugada syndrome patients with a subcutaneous implantable cardiac defibrillator 56
Does the age affect the outcomes of cardiac resynchronization therapy in elderly patients? 56
Correction to: Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry (Clinical Research in Cardiology, (2022), 111, 5, (560-573), 10.1007/s00392-022-01996-2) 56
LDL-cholesterol levels and lipid lowering therapy in secondary prevention. Baseline data from the BRING-UP prospective registry 55
Totale 7.849
Categoria #
all - tutte 40.172
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.172


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202152 0 0 0 0 0 6 11 0 12 15 6 2
2021/202247 9 0 2 1 0 1 1 2 5 1 5 20
2022/2023119 16 12 7 20 7 18 0 12 19 2 5 1
2023/2024493 12 2 1 2 11 4 5 187 0 17 80 172
2024/20254.896 16 91 292 132 172 200 258 856 1.786 730 211 152
2025/20264.676 322 1.662 752 1.077 808 55 0 0 0 0 0 0
Totale 10.504